ACADIA Pharmaceuticals (ACAD) Short Interest Ratio & Short Volume → The Military's $700M 'AI Software Bullet' (From Behind the Markets) (Ad) Free ACAD Stock Alerts $15.05 +0.21 (+1.42%) (As of 10:39 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ACADIA Pharmaceuticals Short Interest DataCurrent Short Interest12,140,000 sharesPrevious Short Interest11,980,000 sharesChange Vs. Previous Month+1.34%Dollar Volume Sold Short$183.31 millionShort Interest Ratio6.7 Days to CoverLast Record DateMay 31, 2024Outstanding Shares165,220,000 sharesPercentage of Shares Shorted7.35%Today's Trading Volume385,898 sharesAverage Trading Volume1,740,417 sharesToday's Volume Vs. Average22% Short Selling ACADIA Pharmaceuticals ? Sign up to receive the latest short interest report for ACADIA Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartACAD Short Interest Over TimeACAD Days to Cover Over TimeACAD Percentage of Float Shorted Over Time Ad Behind the MarketsProtect Your Bank Account from ChinaChina is set to launch a gold-backed currency that could shake the financial world. This move will give them unprecedented power over global finance. And could divert trillions from U.S. Treasury bonds.Discover these 4 simple steps here >>> ACADIA Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/202412,140,000 shares $183.31 million +1.3%N/A6.7 $15.10 5/15/202411,980,000 shares $181.14 million -0.4%N/A6.2 $15.12 4/30/202412,030,000 shares $201.02 million +7.8%N/A6.6 $16.71 4/15/202411,160,000 shares $188.49 million -0.4%N/A6.2 $16.89 3/31/202411,200,000 shares $207.09 million +5.4%N/A6.1 $18.49 3/15/202410,630,000 shares $196.44 million -1.7%N/A5.8 $18.48 Get the Latest News and Ratings for ACAD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ACADIA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/29/202410,810,000 shares $251.22 million +14.8%N/A5.5 $23.24 2/15/20249,420,000 shares $237.20 million +22.7%N/A5.3 $25.18 1/31/20247,680,000 shares $198.99 million -5.3%N/A4.4 $25.91 1/15/20248,110,000 shares $233.00 million +2.5%N/A4.6 $28.73 12/31/20237,910,000 shares $247.66 million +2.9%N/A4.6 $31.31 12/15/20237,690,000 shares $219.78 million -0.5%N/A4 $28.58 11/30/20237,730,000 shares $172.22 million -0.8%N/A4.8 $22.28 11/15/20237,790,000 shares $175.82 million +3.3%N/A5 $22.57 10/31/20237,540,000 shares $170.18 million +4.0%N/A4.7 $22.57 10/15/20237,250,000 shares $167.77 million -19.1%N/A4.4 $23.14 9/30/20238,960,000 shares $186.73 million -16.3%N/A4.8 $20.84 9/15/202310,700,000 shares $264.50 million +5.1%N/A6.6 $24.72 8/31/202310,180,000 shares $275.06 million +4.2%N/A6.5 $27.02 8/15/20239,770,000 shares $280.59 million +10.3%N/A6 $28.72 7/31/20238,860,000 shares $259.07 million +0.9%N/A5.3 $29.24 7/15/20238,780,000 shares $282.54 million +5.0%N/A5.7 $32.18 6/30/20238,360,000 shares $200.22 million -10.9%N/A6.3 $23.95 6/15/20239,380,000 shares $228.78 million -6.6%N/A7 $24.39 5/31/202310,040,000 shares $235.94 million +0.7%N/A6.5 $23.50 5/15/20239,970,000 shares $220.54 million +3.3%N/A6.1 $22.12 4/30/20239,650,000 shares $205.83 million +0.4%6.0%6.1 $21.33 4/15/20239,610,000 shares $172.88 million +17.5%6.0%6 $17.99 3/31/20238,180,000 shares $153.95 million -3.8%5.1%5.2 $18.82 3/15/20238,500,000 shares $168.73 million +5.7%5.3%5.6 $19.85 2/28/20238,040,000 shares $166.35 million -0.3%5.0%6.3 $20.69 2/15/20238,060,000 shares $152.90 million -0.5%5.1%7.1 $18.97 1/31/20238,100,000 shares $154.14 million +1.1%5.1%6.9 $19.03 1/15/20238,010,000 shares $147.38 million -4.5%5.0%6.5 $18.40 12/30/20228,390,000 shares $133.57 million -3.6%5.3%6.8 $15.92 12/15/20228,700,000 shares $131.11 million -10.0%5.5%6.6 $15.07 11/30/20229,670,000 shares $150.66 million +7.0%6.1%7 $15.58 11/15/20229,040,000 shares $141.84 million -13.4%5.7%6.2 $15.69 10/31/202210,440,000 shares $167.35 million +9.7%6.5%6.7 $16.03 10/15/20229,520,000 shares $149.65 million -1.7%6.0%6.1 $15.72Are you prepared for a Chinese "invasion?" (Ad)Recently declassified documents show that while the U.S has been distracted in the Middle East... China had been studying our every move... And preparing themselves for not only an armed conflict with the United StatesHere are 4 steps you can take RIGHT NOW >>> 9/30/20229,680,000 shares $158.36 million +0.8%6.1%5.9 $16.36 9/15/20229,600,000 shares $175.39 million -3.7%6.0%5.4 $18.27 8/31/20229,970,000 shares $163.81 million -1.5%6.3%3.9 $16.43 8/15/202210,120,000 shares $167.99 million +4.7%6.4%3.9 $16.60 7/31/20229,670,000 shares $142.05 million -0.5%6.8%3.7 $14.69 7/15/20229,720,000 shares $148.52 million -7.0%6.8%3.7 $15.28 6/30/202210,450,000 shares $147.24 million -10.8%7.3%4 $14.09 6/15/202211,720,000 shares $219.98 million -9.1%8.2%4.7 $18.77 5/31/202212,890,000 shares $208.17 million -1.0%8.1%7.7 $16.15 5/15/202213,020,000 shares $219.39 million +8.5%8.2%8 $16.85 4/30/202212,000,000 shares $221.28 million +48.0%7.5%7.6 $18.44 4/15/20228,110,000 shares $190.34 million +17.7%5.1%5.3 $23.47 3/31/20226,890,000 shares $166.88 million -3.1%4.3%4.7 $24.22 3/15/20227,110,000 shares $163.89 million +17.9%4.4%4.4 $23.05 2/28/20226,030,000 shares $153.22 million +1.3%3.8%3.5 $25.41 2/15/20225,950,000 shares $162.32 million +6.6%3.7%3.6 $27.28 1/31/20225,580,000 shares $125.49 million -17.3%3.5%3.3 $22.49 1/15/20226,750,000 shares $155.59 million +2.0%4.2%4.1 $23.05 12/31/20216,620,000 shares $154.51 million +1.9%4.1%4.1 $23.34 12/15/20216,500,000 shares $158.47 million +11.9%4.1%4 $24.38 11/30/20215,810,000 shares $111.55 million -20.6%3.6%4.4 $19.20 11/15/20217,320,000 shares $144.72 million -6.5%4.6%5.9 $19.77 10/29/20217,830,000 shares $140.55 million +3.2%4.9%6.3 $17.95 10/15/20217,590,000 shares $132.90 million +6.8%4.8%5.8 $17.51 9/30/20217,110,000 shares $118.10 million +1.3%4.5%5.5 $16.61 9/15/20217,020,000 shares $111.62 million -3.6%4.4%4.5 $15.90 8/31/20217,280,000 shares $127.47 million -7.7%4.6%4.6 $17.51 8/13/20217,890,000 shares $138.71 million -2.6%4.9%4.8 $17.58 7/30/20218,100,000 shares $175.20 million +0.9%5.1%4.7 $21.63 7/15/20218,030,000 shares $185.97 million -1.7%5.0%4.6 $23.16 6/30/20218,170,000 shares $199.27 million +36.9%5.1%4.3 $24.39 6/15/20215,970,000 shares $156.83 million +2.9%3.7%3 $26.27 5/28/20215,800,000 shares $129.57 million -20.0%3.6%2.6 $22.34 5/14/20217,250,000 shares $153.85 million -3.3%N/A2.7 $21.22 4/30/20217,500,000 shares $154.43 million -6.1%N/A2.9 $20.59 4/15/20217,990,000 shares $170.03 million +14.0%N/A3.3 $21.28 3/31/20217,010,000 shares $180.23 million +7.5%N/A3.1 $25.71 3/15/20216,520,000 shares $176.30 million -1.4%N/A3.6 $27.04 2/26/20216,610,000 shares $312.72 million +7.8%N/A5 $47.31 2/12/20216,130,000 shares $314.10 million +1.0%N/A6.8 $51.24 1/29/20216,070,000 shares $300.71 million -2.6%N/A6.4 $49.54 1/15/20216,230,000 shares $339.29 million -1.6%N/A6.2 $54.46 12/31/20206,330,000 shares $339.86 million -10.0%N/A6.4 $53.69 12/15/20207,030,000 shares $366.47 million -10.3%N/A7 $52.13 11/30/20207,840,000 shares $439.04 million -2.0%N/A7.6 $56.00 11/15/20208,000,000 shares $412.56 million -9.5%N/A7.6 $51.57 10/30/20208,840,000 shares $418.57 million -0.6%N/A7.8 $47.35 10/15/20208,890,000 shares $381.56 million -3.5%N/A7.6 $42.92 9/30/20209,210,000 shares $379.91 million +2.7%N/A6.5 $41.25 9/15/20208,970,000 shares $347.95 million -4.0%N/A4.8 $38.79Are you prepared for a Chinese "invasion?" (Ad)Recently declassified documents show that while the U.S has been distracted in the Middle East... China had been studying our every move... And preparing themselves for not only an armed conflict with the United StatesHere are 4 steps you can take RIGHT NOW >>> 8/31/20209,340,000 shares $369.77 million -0.2%N/A5 $39.59 8/14/20209,360,000 shares $368.32 million -5.4%N/A5 $39.35 7/31/20209,890,000 shares $411.13 million +4.1%N/A5.6 $41.57 7/15/20209,500,000 shares $523.74 million -3.3%N/A5.5 $55.13 6/30/20209,820,000 shares $475.98 million -14.5%N/A6.3 $48.47 6/15/202011,490,000 shares $534.17 million +2.3%N/A9.2 $46.49 5/29/202011,230,000 shares $557.91 million -2.4%N/A8.7 $49.68 5/15/202011,510,000 shares $585.05 million +0.1%N/A8.4 $50.83 4/30/202011,500,000 shares $555.57 million -5.2%N/A8.4 $48.31 4/15/202012,130,000 shares $548.15 million +5.7%N/A8.9 $45.19 3/31/202011,480,000 shares $584.68 million -5.3%N/A8.1 $50.93 3/13/202012,117,000 shares $530.72 million +3.4%N/A9.7 $43.80 2/28/202011,720,000 shares $410.20 million +2.2%N/A8.2 $35.00 2/14/202011,470,000 shares $470.38 million -0.4%N/A7.7 $41.01 1/31/202011,510,000 shares $462.93 million +2.1%N/A7.6 $40.22 1/15/202011,270,000 shares $494.53 million +1.5%N/A7.3 $43.88 12/31/201911,100,000 shares $436.67 million +7.1%N/A7.1 $39.34 ACAD Short Interest - Frequently Asked Questions What is ACADIA Pharmaceuticals' current short interest? Short interest is the volume of ACADIA Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 12,140,000 shares of ACAD short. Learn More on ACADIA Pharmaceuticals' current short interest. What is a good short interest ratio for ACADIA Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACAD shares currently have a short interest ratio of 7.0. Learn More on ACADIA Pharmaceuticals's short interest ratio. Which institutional investors are shorting ACADIA Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ACADIA Pharmaceuticals: Walleye Trading LLC, Torno Capital LLC, Twin Tree Management LP, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is ACADIA Pharmaceuticals' short interest increasing or decreasing? ACADIA Pharmaceuticals saw a increase in short interest during the month of May. As of May 31st, there was short interest totaling 12,140,000 shares, an increase of 1.3% from the previous total of 11,980,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ACADIA Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ACADIA Pharmaceuticals: Bausch Health Companies Inc. (4.91%), Mirati Therapeutics, Inc. (6.26%), Insmed Incorporated (7.31%), Elanco Animal Health Incorporated (3.34%), Legend Biotech Co. (7.27%), Roivant Sciences Ltd. (7.28%), Ascendis Pharma A/S (5.87%), Cerevel Therapeutics Holdings, Inc. (8.34%), Intra-Cellular Therapies, Inc. (3.79%), Jazz Pharmaceuticals plc (5.41%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks. What does it mean to sell short ACADIA Pharmaceuticals stock? Short selling ACAD is an investing strategy that aims to generate trading profit from ACADIA Pharmaceuticals as its price is falling. ACAD shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ACADIA Pharmaceuticals? A short squeeze for ACADIA Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACAD, which in turn drives the price of the stock up even further. How often is ACADIA Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACAD, twice per month. The most recent reporting period available is May, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Bausch Health Companies Short Interest Mirati Therapeutics Short Interest Insmed Short Interest Elanco Animal Health Short Interest Legend Biotech Short Interest Roivant Sciences Short Interest Ascendis Pharma A/S Short Interest Cerevel Therapeutics Short Interest Intra-Cellular Therapies Short Interest Jazz Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACAD) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ACADIA Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ACADIA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.